Literature DB >> 17090365

[Guideline for the diagnosis and treatment of liver fibrosis with integrative medicine].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17090365

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN： 1672-1977


× No keyword cloud information.
  3 in total

1.  A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes.

Authors:  Ya-Nan Song; Jian Chen; Fei-Fei Cai; Yi-Yu Lu; Qi-Long Chen; Yong-Yu Zhang; Ping Liu; Shi-Bing Su
Journal:  Acta Pharmacol Sin       Date:  2017-10-26       Impact factor: 6.150

2.  Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism.

Authors:  Qing-Ya Li; Zhi-Zhong Guo; Xin Deng; Lie-Ming Xu; Yue-Qiu Gao; Wei Zhang; Xiao-Su Wang; Dong-Ying Xue; Yi-Yu Lu; Ping Liu; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-24       Impact factor: 2.629

3.  Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail.

Authors:  Ya-Nan Song; Ji-Jia Sun; Yi-Yu Lu; Lie-Ming Xu; Yue-Qiu Gao; Wei Zhang; Xiao-Su Wang; Dong-Ying Xue; Qing-Shan Zheng; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-06       Impact factor: 2.629
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.